University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland
The James Cancer Hospital and Solove Research Institute, Columbus

In reclutamentoFase 1/2

Età da 16 a 75 · Tutti i sessi · Aggiornato il 10 set 2026 · NCT03104491

First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.

Cincinnati Children's Hospital Medical Center, Cincinnati

In reclutamentoFase 1

Età 18 e oltre · Tutti i sessi · Aggiornato il 1 set 2026 · NCT07586618

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Children's Hospital Medical Center of Akron, Akron
Cincinnati Children's Hospital Medical Center, Cincinnati
Rainbow Babies and Childrens Hospital, Cleveland
e altri 3

In reclutamentoFase 1/2

Fino a 22 anni · Tutti i sessi · Aggiornato il 25 ago 2026 · NCT04726241

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Cincinnati Children's Hospital Medical Center, Cincinnati

In reclutamentoFase 2

Età da 7 a 25 · Tutti i sessi · Aggiornato il 19 ago 2026 · NCT05082519

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

Children's Hospital Medical Center, Cincinnati

In reclutamentoStudio osservazionale

1 Day – 17 Years · Tutti i sessi · Aggiornato il 14 ago 2026 · NCT06274788

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Childrens Hospital Medical Center of Akron, Akron
Cincinnati Children's Hospital, Cincinnati
University Hospitals Case Medical Center, Cleveland
e altri 3

In reclutamentoStudio osservazionale

Tutte le età · Tutti i sessi · Aggiornato il 6 lug 2026 · NCT01351545

Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase

Cincinnati Children's Hospital Medical Center, Cincinnati

In reclutamentoFase 1/2

Fino a 21 anni · Tutti i sessi · Aggiornato il 3 giu 2026 · NCT04195347

Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies

Nationwide Children's Hospital, Columbus
Ohio State University Comprehensive Cancer Center, Columbus

In reclutamentoFase 1

Età 2 e oltre · Tutti i sessi · Aggiornato il 29 mag 2026 · NCT05418088

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

Children's Hospital Medical Center of Akron, Akron
Cincinnati Children's Hospital Medical Center, Cincinnati

In reclutamentoStudio osservazionale

Tutte le età · Tutti i sessi · Aggiornato il 18 mag 2026 · NCT01790152

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

Cincinnati Children's Hospital Medical Center, Cincinnati
University of Cincinnati, Cincinnati
The Ohio State University, Columbus

In reclutamentoFase 1

Età 13 e oltre · Tutti i sessi · Aggiornato il 5 mag 2026 · NCT04771572

Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide

Ohio State University Medical Center, Columbus

In reclutamentoFase 1

Età da 18 a 65 · Tutti i sessi · Aggiornato il 25 mar 2026 · NCT03533816

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

The Ohio State University Comprehensive Cancer Center, Columbus

In reclutamentoFase 1/2

Età 12 e oltre · Tutti i sessi · Aggiornato il 24 mar 2026 · NCT04988555

Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Cleveland Clinic Foundation, Cleveland

In reclutamentoFase 2

Età da 18 a 54 · Tutti i sessi · Aggiornato il 17 mar 2026 · NCT06918431

Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

Cleveland Clinic, Cleveland

In reclutamentoFase 1

Età 18 e oltre · Tutti i sessi · Aggiornato il 5 nov 2025 · NCT04260022

HPC Offered for PRESERVE Expansion

The Ohio State University Medical Center, Columbus

In reclutamentoStudio osservazionale

Età da 12 a 80 · Tutti i sessi · Aggiornato il 28 ago 2025 · NCT07145411

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Cincinnati Children's Hospital Medical Center, Cincinnati
Rainbow Babies, Cleveland
Nationwide Children's Hospital, Columbus

In reclutamentoFase 1

Età da 1 a 21 · Tutti i sessi · Aggiornato il 6 dic 2024 · NCT05476770

Fonte: ClinicalTrials.gov, dati recuperati il 3 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.